DNAJA2 and Hero11 mediate similar conformational extension and aggregation suppression of TDP-43
RNA · 2024-11 · 30 (11) · 1422-1436
DOI: 10.1261/rna.080165.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, online erschienen am 08.08.2024. Verfasst von Andy Y W Lam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Quantitative Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan. Hauptthemen laut MEDLINE: DNA-Binding Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Many RNA-binding proteins (RBPs) contain low-complexity domains (LCDs) with prion-like compositions. These long intrinsically disordered regions regulate their solubility, contributing to their physiological roles in RNA processing and organization. However, this also makes these RBPs prone to pathological misfolding and aggregation that are characteristic of neurodegenerative diseases. For example, TAR DNA-binding protein 43 (TDP-43) forms pathological aggregates associated with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). While molecular chaperones are well-known suppressors of these aberrant events, we recently reported that highly disordered, hydrophilic, and charged heat-resistant obscure (Hero) proteins may have similar effects. Specifically, Hero proteins can maintain the activity of other proteins from denaturing conditions in vitro, while their overexpression can suppress cellular aggregation and toxicity associated with aggregation-prone proteins. However, it is unclear how these protective effects are achieved. Here, we used single-molecule FRET to monitor the conformations of the aggregation-prone prion-like LCD of TDP-43. While we observed high conformational heterogeneity in wild-type LCD, the ALS-associated mutation A315T promoted collapsed conformations. In contrast, an Hsp40 chaperone, DNAJA2, and a Hero protein, Hero11, stabilized extended states of the LCD, consistent with their ability to suppress the aggregation of TDP-43. Our results link single-molecule effects on conformation to macro effects on bulk aggregation, where a Hero protein, like a chaperone, can maintain the conformational integrity of a client protein to prevent its aggregation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Quantitative Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan.
- Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan.
- Institute of Industrial Science, the University of Tokyo, Meguro-ku, Tokyo 153-8505, Japan.
- School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, People's Republic of China.
- Institute for Quantitative Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan tomari@iqb.u-tokyo.ac.jp.
ORCID-Profile: Yukihide Tomari
Zitieren
APA
Lam, A. Y. W., Tsuboyama, K., Tadakuma, H., & Tomari, Y. (2024). DNAJA2 and Hero11 mediate similar conformational extension and aggregation suppression of TDP-43. RNA, 30(11), 1422-1436. https://doi.org/10.1261/rna.080165.124
Vancouver
Lam AYW, Tsuboyama K, Tadakuma H, Tomari Y. DNAJA2 and Hero11 mediate similar conformational extension and aggregation suppression of TDP-43. RNA. 2024;30(11):1422-1436. doi:10.1261/rna.080165.124
BibTeX
@article{Lam2024,
author = {Lam, Andy Y W and Tsuboyama, Kotaro and Tadakuma, Hisashi and Tomari, Yukihide},
title = {DNAJA2 and Hero11 mediate similar conformational extension and aggregation suppression of TDP-43},
journal = {RNA},
year = {2024},
volume = {30},
number = {11},
pages = {1422--1436},
doi = {10.1261/rna.080165.124}
}
EUVIMED